At the news
? NEUTRALIMPACT 3/10 6-K filed Apr 27, 2026 at 08:10 ET
Evaxion A/S announced the promotion of Birgitte Rn from Chief Scientific Officer (CSO) to a dual role as CSO and Chief Operating Officer (COO), citing organizational alignment and her long-standing operational and scientific contributions. The move is intended to enhance external engagement and strategy execution around its AI-Immunology platform.
- Birgitte Rn promoted from CSO to joint CSO and COO role at Evaxion A/S
- Promotion follows internal management review aimed at improving external visibility and strategic execution
- No changes to other executive roles; management team remains stable
- No financial terms, compensation changes, or structural reorganization disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access